SinuSonic
Revolutionizing Nasal Congestion Treatment

According to a 2021 survey by The Harris On Demand, nearly one in four people experience nasal congestion almost every day, with the majority (85 percent) reporting that congestion negatively impacts their daily activities. With such numbers, it is fair to say that millions of Americans are affected by chronic nasal congestion. However, even with millions afflicted by this problem, treatment for nasal congestion has not had a breakthrough since the turn of the century. From antihistamines and steroidal drugs to saline sprays, no treatment option has shown the efficacy to deliver long-term relief.

Addressing this issue with its revolutionary, drug-free, congestion relief solution is South Carolina-based SinuSonic. “SinuSonic is the only patented medical device that uses a combination of gentle acoustic vibrations and light resistant pressure to help open nasal breathing and relieve nasal congestion,” says David Lewis, managing partner at SinuSonic. At the same time, instead of a contemporary to existing nasal congestion treatment options, SinuSonic acts symbiotically, enabling the effective dissemination of nasal sprays throughout a patient’s sinues.

Founded in 2017, SinuSonic was invented by David Lewis and Dr. Richard K. Bogan, long-time partners in health ventures related to sleep medicine. It all started after Dr. Bogan personally ‘discovered’ the positive impact that light acoustic vibrations provided to his own nasal congestion. After exhaustive research, product designs and testing, and initial trials in conjunction with the University of Carolina, the solution showcased an efficacy of 80 percent in treating chronically congested patients.The company also tested its solution using peak nasal inspiratory flow (PNIF), which showed a 15 percent increase in air flow after two weeks of consistent SinuSonic usage. Since then, the team behind SinuSonic also recognized that acoustic vibrations increases the body’s production of nitric oxide, which is a natural stimulant that excites nasal hair and drives faster mucus clearance.

SinuSonic is the only patented medical device that uses a combination of gentle acoustic vibrations and light resistant pressure to help open nasal breathing and relieve nasal congestion

With respect to customer engagement, SinuSonic opts for a two-way approach, one for medical professionals where the company educates doctors on the science of SinuSonic and the second for end-consumers where it spreads awareness of its solution as a natural alternative for nasal congestion treatment. These consumers fall under different categories, namely, individuals with chronic and seasonal congestion, pregnant women, and sleep apnea patients that cannot utilize their C-PAP masks because of congestion. Further discussing the core competencies of SinuSonic, Lewis elaborates, “We did not want to sell a gimmick and thus, we have always worked closely with top rhinologists to bolster the impact of our solution in delivering long-term relief.” In fact, the company consulted with Dr. Rodney Schlosser—the president of the American Rhinological Society—who corroborated the efficacy of SinuSonic in a paper that was published in the international forum of allergy and rhinology.

SinuSonic has also run several surveys where the company noticed that a significant number of users (87 percent) recommended the use of its solution to family members or friends. More recently, the company finished two large trials where patients with chronic sinus headaches were enrolled to evaluate the efficacy of SinuSonic. After four weeks of use, patients reported significant improvement in pain, visual analog scale, the brief pain inventory and the McGill pain questionnaire. This study is currently in the process of submission and will soon be published in The White Journal ENT.

Looking ahead, Lewis envisions using SinuSonic as an avenue to open up nasal airways and utilize it as a platform for medication delivery. And with its proven ability to increase airflow, Lewis plans to leverage SinuSonic and capitalize on the opportunity it creates to effectively distribute drugs to previously stuffy sinuses and ostia. “SinuSonic’s combination of PEP and acoustic vibration is perfectly poised to unlock a whole new market for us in the form of medication delivery,” concludes Lewis.